314 related articles for article (PubMed ID: 9663809)
61. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
Tack CJ; Ong MK; Lutterman JA; Smits P
Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
[TBL] [Abstract][Full Text] [Related]
62. [Role of endothelium-derived nitric oxide in sustained flow-dependent dilatation of human peripheral conduit arteries].
Bellien J; Joannidès R; Iacob M; Eltchaninoff H; Thuillez Ch
Arch Mal Coeur Vaiss; 2003; 96(7-8):738-41. PubMed ID: 12945214
[TBL] [Abstract][Full Text] [Related]
63. The nitric oxide synthase inhibitor L-NMMA potentiates noradrenaline-induced vasoconstriction: effects of the alpha2-receptor antagonist yohimbine.
Bruck H; Gössl M; Spitthöver R; Schäfers RF; Kohnle M; Philipp T; Wenzel RR
J Hypertens; 2001 May; 19(5):907-11. PubMed ID: 11393674
[TBL] [Abstract][Full Text] [Related]
64. Tissue viability imaging: microvascular response to vasoactive drugs induced by iontophoresis.
Henricson J; Nilsson A; Tesselaar E; Nilsson G; Sjöberg F
Microvasc Res; 2009 Sep; 78(2):199-205. PubMed ID: 19409397
[TBL] [Abstract][Full Text] [Related]
65. Vasopressin effects on the coronary circulation after a short ischemia in anesthetized goats: role of nitric oxide and prostanoids.
Diéguez G; Martínez MA; Fernández N; Climént B; García-Villalón AL; Monge L
Eur J Pharmacol; 2004 Jul; 495(2-3):171-7. PubMed ID: 15249167
[TBL] [Abstract][Full Text] [Related]
66. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease.
Lieberman EH; Gerhard MD; Uehata A; Selwyn AP; Ganz P; Yeung AC; Creager MA
Am J Cardiol; 1996 Dec; 78(11):1210-4. PubMed ID: 8960576
[TBL] [Abstract][Full Text] [Related]
67. [Vasodilator effects of bradykinin on the resistive circulation of the forearm of coronary patients].
Benacerraf S; Carville C; Sediame S; Belhassen L; Adnot S; Dubois-Randé JL
Arch Mal Coeur Vaiss; 2000 Sep; 93(9):1103-8. PubMed ID: 11055001
[TBL] [Abstract][Full Text] [Related]
68. Skin microvascular dilatation response to acetylcholine and sodium nitroprusside in peripheral arterial disease.
Jägrén C; Gazelius B; Ihrman-Sandal C; Lindblad LE; Ostergren J
Clin Physiol Funct Imaging; 2002 Nov; 22(6):370-4. PubMed ID: 12464139
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of p38 mitogen-activated protein kinase improves nitric oxide-mediated vasodilatation and reduces inflammation in hypercholesterolemia.
Cheriyan J; Webb AJ; Sarov-Blat L; Elkhawad M; Wallace SM; Mäki-Petäjä KM; Collier DJ; Morgan J; Fang Z; Willette RN; Lepore JJ; Cockcroft JR; Sprecher DL; Wilkinson IB
Circulation; 2011 Feb; 123(5):515-23. PubMed ID: 21262998
[TBL] [Abstract][Full Text] [Related]
70. Endothelium-derived nitric oxide mediates hypoxic vasodilation of resistance vessels in humans.
Blitzer ML; Lee SD; Creager MA
Am J Physiol; 1996 Sep; 271(3 Pt 2):H1182-5. PubMed ID: 8853358
[TBL] [Abstract][Full Text] [Related]
71. Abnormal desmopressin-induced forearm vasodilatation in patients with heart failure: dependence on nitric oxide synthase activity.
Rector TS; Bank AJ; Tschumperlin LK; Mullen KA; Lin KA; Kubo SH
Clin Pharmacol Ther; 1996 Dec; 60(6):667-74. PubMed ID: 8988069
[TBL] [Abstract][Full Text] [Related]
72. Reproducibility of laser Doppler imaging of skin blood flow as a tool to assess endothelial function.
Kubli S; Waeber B; Dalle-Ave A; Feihl F
J Cardiovasc Pharmacol; 2000 Nov; 36(5):640-8. PubMed ID: 11065225
[TBL] [Abstract][Full Text] [Related]
73. Contribution of nitric oxide to coronary vasodilation during hypercapnic acidosis.
Gurevicius J; Salem MR; Metwally AA; Silver JM; Crystal GJ
Am J Physiol; 1995 Jan; 268(1 Pt 2):H39-47. PubMed ID: 7530920
[TBL] [Abstract][Full Text] [Related]
74. Increased bioavailability of nitric oxide after lipid-lowering therapy in hypercholesterolemic patients: a randomized, placebo-controlled, double-blind study.
John S; Schlaich M; Langenfeld M; Weihprecht H; Schmitz G; Weidinger G; Schmieder RE
Circulation; 1998 Jul; 98(3):211-6. PubMed ID: 9697820
[TBL] [Abstract][Full Text] [Related]
75. Enhanced vasodilation to acetylcholine in athletes is associated with lower plasma cholesterol.
Kingwell BA; Tran B; Cameron JD; Jennings GL; Dart AM
Am J Physiol; 1996 Jun; 270(6 Pt 2):H2008-13. PubMed ID: 8764251
[TBL] [Abstract][Full Text] [Related]
76. Flow-mediated nitric oxide activity in the forearm vasculature of premenopausal women.
Anumba DO; Robson SC; Ford GA
Br J Clin Pharmacol; 2002 Mar; 53(3):332-6. PubMed ID: 11874398
[TBL] [Abstract][Full Text] [Related]
77. Characterization of ATP-induced vasodilation in the human forearm vascular bed.
Rongen GA; Smits P; Thien T
Circulation; 1994 Oct; 90(4):1891-8. PubMed ID: 7923677
[TBL] [Abstract][Full Text] [Related]
78. Contribution of nitric oxide and prostaglandins to reactive hyperemia in human forearm.
Engelke KA; Halliwill JR; Proctor DN; Dietz NM; Joyner MJ
J Appl Physiol (1985); 1996 Oct; 81(4):1807-14. PubMed ID: 8904603
[TBL] [Abstract][Full Text] [Related]
79. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation.
Duffy SJ; Castle SF; Harper RW; Meredith IT
Circulation; 1999 Nov; 100(19):1951-7. PubMed ID: 10556220
[TBL] [Abstract][Full Text] [Related]
80. Vascular responses of the extremities to transdermal application of vasoactive agents in Caucasian and African descent individuals.
Maley MJ; House JR; Tipton MJ; Eglin CM
Eur J Appl Physiol; 2015 Aug; 115(8):1801-11. PubMed ID: 25840674
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
